Grown Rogue International (GRUSF) Cash & Equivalents (2009 - 2026)
Grown Rogue International (GRUSF) recorded quarterly Cash & Equivalents of $13.7 million in Q1 2026, up 20.48% quarter-over-quarter from $11.4 million in Q4 2025, and up 319.88% on a YoY basis from $3.3 million in Q1 2025.
Grown Rogue International (GRUSF) Cash & Equivalents (2009 - 2026) Analysis & Trends
Grown Rogue International's Cash & Equivalents history runs 18 years deep, the most recent figure standing at $13.7 million for Q1 2026.
- In Q1 2026, Cash & Equivalents rose 319.88% year-over-year to $13.7 million; the TTM figure through Mar 2026 stood at $13.7 million (up 319.88% YoY), while the FY2025 annual figure was $11.4 million, up 131.24% from the prior year.
- Cash & Equivalents was $13.7 million for Q1 2026 at Grown Rogue International, up from $11.4 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $4682.2 billion in Q3 2025 to a low of $0.84 in Q4 2022.
- Historically, Cash & Equivalents has averaged $275.4 billion across 5 years, with a median of $3.5 million in 2023.
- The sharpest annual moves came in 2022 and 2023: Cash & Equivalents sank 100.0% in 2022, then surged 139135284.87% in 2023.
- A 5-year view of Cash & Equivalents shows it stood at $0.84 in 2022, then surged by 775760783.71% to $6.5 million in 2023, then sank by 48.49% to $3.4 million in 2024, then soared by 239.28% to $11.4 million in 2025, then gained by 20.48% to $13.7 million in 2026.
- The last three Cash & Equivalents figures came in at $13.7 million (Q1 2026), $11.4 million (Q4 2025), and $4682.2 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 3.74 Bn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 1.94 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 1.28 Bn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 266.50 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | 47.17 Mn |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 428.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | 351.55 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 498.58 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 222.79 Mn |
| 10 | Grown Rogue International | - | - | 3.96 Mn | 13.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.70 Mn |
| Dec 31, 2025 | 11.37 Mn |
| Sep 30, 2025 | 4,682.22 Bn |
| Jun 30, 2025 | 3.38 Mn |
| Mar 31, 2025 | 3.26 Mn |
| Dec 31, 2024 | 3.35 Mn |
| Sep 30, 2024 | 4.10 Mn |
| Jun 30, 2024 | 4.98 Mn |
| Mar 31, 2024 | 9.45 Mn |
| Dec 31, 2023 | 6.51 Mn |
| Oct 31, 2023 | 1.17 Mn |
| Jul 31, 2023 | 3.49 Mn |
| Apr 30, 2023 | 1.58 Mn |
| Jan 31, 2023 | 3.49 Mn |
| Oct 31, 2022 | 0.84 |
| Apr 30, 2022 | 1.11 Mn |
| Jan 31, 2022 | 1.11 Mn |
| Oct 31, 2021 | 173,236.80 |
| Jul 31, 2021 | 217,788.00 |
| Apr 30, 2021 | 217,788.00 |